| TAK1 is a central mediator of NOD2 signaling in epidermal cells JY Kim, E Omori, K Matsumoto, G Núñez, J Ninomiya-Tsuji Journal of Biological Chemistry 283 (1), 137-144, 2008 | 123 | 2008 |
| Dissection of TBK1 signaling via phosphoproteomics in lung cancer cells JY Kim, EA Welsh, U Oguz, B Fang, Y Bai, F Kinose, C Bronk, LLR Rix, ... Proceedings of the National Academy of Sciences 110 (30), 12414-12419, 2013 | 116 | 2013 |
| Merlin, a tumor suppressor, interacts with transactivation-responsive RNA-binding protein and inhibits its oncogenic activity JY Lee, H Kim, CH Ryu, JY Kim, BH Choi, Y Lim, PW Huh, YH Kim, ... Journal of Biological Chemistry 279 (29), 30265-30273, 2004 | 79 | 2004 |
| Targeting tumor adaption to chronic hypoxia: implications for drug resistance, and how it can be overcome JY Kim, JY Lee International journal of molecular sciences 18 (9), 1854, 2017 | 76 | 2017 |
| TAK1-binding protein 1, TAB1, mediates osmotic stress-induced TAK1 activation but is dispensable for TAK1-mediated cytokine signaling M Inagaki, E Omori, JY Kim, Y Komatsu, G Scott, MK Ray, G Yamada, ... Journal of Biological Chemistry 283 (48), 33080-33086, 2008 | 75 | 2008 |
| Postmortem proteomics to discover biomarkers for forensic PMI estimation KM Choi, A Zissler, E Kim, B Ehrenfellner, E Cho, S Lee, P Steinbacher, ... International journal of legal medicine 133 (3), 899-908, 2019 | 66 | 2019 |
| Phosphoproteomics reveals MAPK inhibitors enhance MET-and EGFR-driven AKT signaling in KRAS-mutant lung cancer JY Kim, EA Welsh, B Fang, Y Bai, F Kinose, SA Eschrich, JM Koomen, ... Molecular Cancer Research 14 (10), 1019-1029, 2016 | 59 | 2016 |
| Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms J Li, K Bennett, A Stukalov, B Fang, G Zhang, T Yoshida, I Okamoto, ... Molecular systems biology 9 (1), 705, 2013 | 53 | 2013 |
| Cell signaling heterogeneity is modulated by both cell-intrinsic and-extrinsic mechanisms: An integrated approach to understanding targeted therapy E Kim, JY Kim, MA Smith, EB Haura, ARA Anderson PLoS biology 16 (3), e2002930, 2018 | 51 | 2018 |
| Adaptive responses to dasatinib-treated lung squamous cell cancer cells harboring DDR2 mutations Y Bai, JY Kim, JM Watters, B Fang, F Kinose, L Song, JM Koomen, ... Cancer research 74 (24), 7217-7228, 2014 | 47 | 2014 |
| GCA links TRAF6-ULK1-dependent autophagy activation in resistant chronic myeloid leukemia SH Han, S Korm, YG Han, SY Choi, SH Kim, HJ Chung, K Park, JY Kim, ... Autophagy 15 (12), 2076-2090, 2019 | 40 | 2019 |
| Intestinal epithelial-derived TAK1 signaling is essential for cytoprotection against chemical-induced colitis JY Kim, R Kajino-Sakamoto, E Omori, C Jobin, J Ninomiya-Tsuji PloS one 4 (2), e4561, 2009 | 35 | 2009 |
| Inhibition of NF-κB activation by merlin JY Kim, H Kim, SS Jeun, SJ Rha, YH Kim, YJ Ko, J Won, KH Lee, HK Rha, ... Biochemical and biophysical research communications 296 (5), 1295-1302, 2002 | 34 | 2002 |
| Target identification in small cell lung cancer via integrated phenotypic screening and activity-based protein profiling J Li, B Fang, F Kinose, Y Bai, JY Kim, YA Chen, U Rix, JM Koomen, ... Molecular cancer therapeutics 15 (2), 334-342, 2016 | 28 | 2016 |
| Non-canonical IKKs, IKKϵ and TBK1, as novel therapeutic targets in the treatment of non-small cell lung cancer JY Kim, AA Beg, EB Haura Expert opinion on therapeutic targets 17 (10), 1109-1112, 2013 | 21 | 2013 |
| Radiation sensitivity and tumor susceptibility in ATM phospho-mutant ATF2 mice S Li, S Ezhevsky, A Dewing, MH Cato, M Scortegagna, A Bhoumik, ... Genes & cancer 1 (4), 316-330, 2010 | 21 | 2010 |
| HDAC6 deficiency induces apoptosis in mesenchymal stem cells through p53 K120 acetylation SY Park, S Phorl, S Jung, K Sovannarith, S Lee, S Noh, M Han, R Naskar, ... Biochemical and biophysical research communications 494 (1-2), 51-56, 2017 | 19 | 2017 |
| Mathematical modeling of p53 pathways E Kim, JY Kim, JY Lee International journal of molecular sciences 20 (20), 5179, 2019 | 18 | 2019 |
| Activity-Based Protein Profiling Reveals Potential Dasatinib Targets in Gastric Cancer KM Choi, E Cho, G Bang, SJ Lee, B Kim, JH Kim, SG Park, EH Han, ... International journal of molecular sciences 21 (23), 9276, 2020 | 14 | 2020 |
| TAK1 mediates lipopolysaccharide-induced RANTES promoter activation in BV-2 microglial cells. SB Jang, J Won, H Kim, J Kim, KH Lee, H Han, HK Rha, CR Choi Molecules and cells 14 (1), 35-42, 2002 | 12 | 2002 |
